Can we guard ourselves against respiratory viruses with probiotics? In one of our follow-up projects, an innovative approach based on probiotic strains is being investigated in experimental models of the Respiratory Syncytial Virus (RSV). RSV is the leading cause of severe lower respiratory tract disease in young children worldwide. One of the things we want to investigate in this project is whether probiotics can function as immunomodulatory agents that can prevent RSV-associated inflammation in the airways.
More information can be found here.